Mapping the Epitopes of a Neutralizing Antibody Fragment Directed against the Lethal Factor of Bacillus anthracis and Cross-Reacting with the Homologous Edema Factor

nork Thullier, Philippe, Avril, Arnaud, Mathieu, Jacques, Behrens, Christian K., Pellequer, Jean-Luc, Pelat, Thibaut
Argitaratua 2013

Herpes Simplex Virus Type 1 Infection of Activated Cytotoxic T Cells: Induction of Fratricide as a Mechanism of Viral Immune Evasion

nork Raftery, Martin J., Behrens, Christian K., Müller, Anke, Krammer, Peter H., Walczak, Henning, Schönrich, Günther
Argitaratua 1999

Selection of IgG Variants with Increased FcRn Binding Using Random and Directed Mutagenesis: Impact on Effector Functions

nork Monnet, Céline, Jorieux, Sylvie, Urbain, Rémi, Fournier, Nathalie, Bouayadi, Khalil, De Romeuf, Christophe, Behrens, Christian K., Fontayne, Alexandre, Mondon, Philippe
Argitaratua izan da Front Immunol (2015)

Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody

nork Monnet, Céline, Jorieux, Sylvie, Souyris, Nathalie, Zaki, Ouafa, Jacquet, Alexandra, Fournier, Nathalie, Crozet, Fabien, de Romeuf, Christophe, Bouayadi, Khalil, Urbain, Rémi, Behrens, Christian K, Mondon, Philippe, Fontayne, Alexandre
Argitaratua 2014

Rise and Fall of an Anti-MUC1 Specific Antibody

nork Thie, Holger, Toleikis, Lars, Li, Jiandong, von Wasielewski, Reinhard, Bastert, Gunther, Schirrmann, Thomas, Esteves, Isabel Tourais, Behrens, Christian K., Fournes, Bénédict, Fournier, Nathalie, de Romeuf, Christophe, Hust, Michael, Dübel, Stefan
Argitaratua 2011

The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer: Validation using the mAb 12G4

nork Kersual, Nathalie, Garambois, Véronique, Chardès, Thierry, Pouget, Jean-Pierre, Salhi, Imed, Bascoul-Mollevi, Caroline, Bibeau, Frédéric, Busson, Muriel, Vié, Henri, Clémenceau, Béatrice, Behrens, Christian K, Estupina, Pauline, Pèlegrin, André, Navarro-Teulon, Isabelle
Argitaratua izan da MAbs (2014)